{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:42:11Z","timestamp":1785469331775,"version":"3.56.0"},"reference-count":114,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rett syndrome (RTT) is a multisystem neurological disorder. Pathogenic changes in the MECP2 gene that codes for methyl-CpG-binding protein 2 (MeCP2) in RTT lead to a loss of previously established motor and cognitive skills. Unravelling the mechanisms of neurological regression in RTT is complex, due to multiple components of the neural epigenome being affected. Most evidence has primarily focused on deciphering the complexity of transcriptional machinery at the molecular level. Little attention has been paid to how epigenetic changes across the neural epigenome in RTT lead to neurological regression. In this narrative review, we examine how pathogenic changes in MECP2 can disrupt the balance of the RTT neural epigenome and lead to neurological regression. Environmental and genetic factors can disturb the balance of the neural epigenome in RTT, modifying the onset of neurological regression. Methylation changes across the RTT neural epigenome and the consequent genotoxic stress cause neurons to regress into a senescent state. These changes influence the brain as it matures and lead to the emergence of specific symptoms at different developmental periods. Future work could focus on epidrugs or epi-editing approaches that may theoretically help to restore the epigenetic imbalance and thereby minimise the impact of genotoxic stress on the RTT neural epigenome.<\/jats:p>","DOI":"10.3390\/ijms26115361","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:55:52Z","timestamp":1748951752000},"page":"5361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular Insights into Neurological Regression with a Focus on Rett Syndrome\u2014A Narrative Review"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-856X","authenticated-orcid":false,"given":"Jatinder","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London SE5 8AF, UK"},{"name":"Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD), South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK"},{"name":"Centre for Interventional Paediatric Psychopharmacology (CIPP) Rett Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London SE5 8AF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-5893","authenticated-orcid":false,"given":"Paramala","family":"Santosh","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London SE5 8AF, UK"},{"name":"Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD), South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK"},{"name":"Centre for Interventional Paediatric Psychopharmacology (CIPP) Rett Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London SE5 8AF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Younesian, S., Yousefi, A.M., Momeny, M., Ghaffari, S.H., and Bashash, D. (2022). The DNA Methylation in Neurological Diseases. Cells, 11.","DOI":"10.3390\/cells11213439"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lu, H., Liu, X., Deng, Y., and Qing, H. (2013). DNA methylation, a hand behind neurodegenerative diseases. Front. Aging Neurosci., 5.","DOI":"10.3389\/fnagi.2013.00085"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Vuu, Y.M., Roberts, C.T., and Rastegar, M. (2023). MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044218"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrg.2016.83","article-title":"Transcription factors as readers and effectors of DNA methylation","volume":"17","author":"Zhu","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Roberts, C.T., Arezoumand, K.S., Kadar Shahib, A., Davie, J.R., and Rastegar, M. (2024). Epigenetics in rare neurological diseases. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1413248"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Li, L., Chen, R., Zhang, H., Li, J., Huang, H., Weng, J., Tan, H., Guo, T., Wang, M., and Xie, J. (2024). The epigenetic modification of DNA methylation in neurological diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1401962"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/46052","article-title":"Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene","volume":"402","author":"Xu","year":"1999","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmed.2012.10.008","article-title":"Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis","volume":"19","author":"Koch","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","article-title":"Extensive changes in DNA methylation are associated with expression of mutant huntingtin","volume":"110","author":"Ng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/hmg\/ddw076","article-title":"DNA methylation profiling in human Huntington\u2019s disease brain","volume":"25","author":"Islam","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-023-00443-4","article-title":"Imprinting disorders","volume":"9","author":"Eggermann","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","article-title":"Prader-Willi syndrome: A review of clinical, genetic, and endocrine findings","volume":"38","author":"Angulo","year":"2015","journal-title":"J. Endocrinol. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114700","DOI":"10.1016\/j.celrep.2024.114700","article-title":"Parent-of-origin-specific DNA replication timing is confined to large imprinted regions","volume":"43","author":"Edwards","year":"2024","journal-title":"Cell Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jmg-2024-110115","article-title":"Long-read sequencing for detection and subtyping of Prader-Willi and Angelman syndromes","volume":"62","author":"Akbari","year":"2024","journal-title":"J. Med. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Van Gils, J., Magdinier, F., Fergelot, P., and Lacombe, D. (2021). Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder. Genes, 12.","DOI":"10.3390\/genes12070968"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/neuonc\/nox183","article-title":"Glioma CpG island methylator phenotype (G-CIMP): Biological and clinical implications","volume":"20","author":"Malta","year":"2018","journal-title":"Neuro-Oncology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41586-020-2574-4","article-title":"MeCP2 links heterochromatin condensates and neurodevelopmental disease","volume":"586","author":"Li","year":"2020","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liu, Y., Whitfield, T.W., Bell, G.W., Guo, R., Flamier, A., Young, R.A., and Jaenisch, R. (2025). Exploring the complexity of MECP2 function in Rett syndrome. Nat. Rev. Neurosci., 1\u201320.","DOI":"10.1038\/s41583-025-00926-1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajmg.a.34418","article-title":"Genotype-phenotype relationships as prognosticators in Rett syndrome should be handled with care in clinical practice","volume":"158A","author":"Halbach","year":"2012","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Singh, J., and Santosh, P. (2024). The Newborn Screening Programme Revisited: An Expert Opinion on the Challenges of Rett Syndrome. Genes, 15.","DOI":"10.3390\/genes15121570"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e63725","DOI":"10.1002\/ajmg.a.63725","article-title":"Rett syndrome diagnostic odyssey: Limitations of NextGen sequencing","volume":"194","author":"Abbott","year":"2024","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"RettSearch Consortium. Rett syndrome: Revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13023-018-0873-8","article-title":"Key issues in Rett syndrome: Emotional, behavioural and autonomic dysregulation (EBAD)\u2014A target for clinical trials","volume":"13","author":"Singh","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/pcn.13299","article-title":"Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated clinical considerations","volume":"75","author":"Singh","year":"2021","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gulmez Karaca, K., Brito, D.V.C., and Oliveira, A.M.M. (2019). MeCP2: A Critical Regulator of Chromatin in Neurodevelopment and Adult Brain Function. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184577"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41572-024-00568-0","article-title":"Rett syndrome","volume":"10","author":"Gold","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Marano, D., Fioriniello, S., D\u2019Esposito, M., and Della Ragione, F. (2021). Transcriptomic and Epigenomic Landscape in Rett Syndrome. Biomolecules, 11.","DOI":"10.3390\/biom11070967"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vidal, S., Xiol, C., Pascual-Alonso, A., O\u2019Callaghan, M., Pineda, M., and Armstrong, J. (2019). Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163925"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-024-03046-8","article-title":"Rett syndrome in Ireland: A demographic study","volume":"19","author":"Zade","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neubiorev.2019.01.028","article-title":"Regression in Rett syndrome: Developmental pathways to its onset","volume":"98","author":"Einspieler","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neubiorev.2019.05.013","article-title":"Rett syndrome before regression: A time window of overlooked opportunities for diagnosis and intervention","volume":"107","author":"Cosentino","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neubiorev.2019.07.005","article-title":"Can Rett syndrome be diagnosed before regression?","volume":"104","author":"Neul","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neubiorev.2019.06.038","article-title":"Rett syndrome and developmental regression","volume":"104","author":"Smeets","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2018.12.009","article-title":"Disturbed redox homeostasis and oxidative stress: Potential players in the developmental regression in Rett syndrome","volume":"98","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.11.014","article-title":"Addressing sequelae of developmental regression associated with developmental disabilities: A systematic review of behavioral and educational intervention studies","volume":"96","author":"Sigafoos","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.25797","article-title":"Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study","volume":"88","author":"Armstrong","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.52269","article-title":"Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2-allelic disorders","volume":"12","author":"Pehlivan","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tamaoki, Y., Kroon, S.L., Williams, B.M., Riley, J.R., and Engineer, C.T. (2025). Early neural dysfunction reflected in degraded auditory cortex responses in pre-regression heterozygous Mecp2 rats. Neurobiol. Dis., 210.","DOI":"10.1016\/j.nbd.2025.106926"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sharifi, O., Haghani, V., Neier, K.E., Fraga, K.J., Korf, I., Hakam, S.M., Quon, G., Johansen, N., Yasui, D.H., and LaSalle, J.M. (2024). Sex-specific single cell-level transcriptomic signatures of Rett syndrome disease progression. Commun. Biol., 7.","DOI":"10.1038\/s42003-024-06990-0"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-025-03644-0","article-title":"Caregiver burden and familial impact in Down Syndrome Regression Disorder","volume":"20","author":"Chow","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108521","DOI":"10.1016\/j.ymgme.2024.108521","article-title":"Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy","volume":"142","author":"Adang","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.braindev.2020.02.003","article-title":"Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome","volume":"42","author":"Ahn","year":"2020","journal-title":"Brain Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddab280","article-title":"Developmental Synaptopathies Consortium. Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: Results from the developmental synaptopathies consortium","volume":"31","author":"Levy","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11689-024-09541-0","article-title":"Developmental Synaptopathies Consortium. Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome","volume":"16","author":"Levy","year":"2024","journal-title":"J. Neurodev. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neubiorev.2019.08.014","article-title":"Towards a consensus on developmental regression","volume":"107","author":"Zhang","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cortex.2023.09.001","article-title":"Developmental regression in children: Current and future directions","volume":"169","author":"Furley","year":"2023","journal-title":"Cortex"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Santoro, J.D., Patel, L., Kammeyer, R., Filipink, R.A., Gombolay, G.Y., Cardinale, K.M., de Asua, D.R., Zaman, S., Santoro, S.L., and Marzouk, S.M. (2022). Assessment and Diagnosis of Down Syndrome Regression Disorder: International Expert Consensus. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.940175"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Fernandez, A., Drozd, M.M., Th\u00fcmmler, S., Dor, E., Capovilla, M., Askenazy, F., and Bardoni, B. (2019). Childhood-Onset Schizophrenia: A Systematic Overview of Its Genetic Heterogeneity From Classical Studies to the Genomic Era. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.01137"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1192\/bjo.2024.840","article-title":"The diagnostic conundrum of late-onset developmental regression in child psychiatry: Case series","volume":"11","author":"Abraham","year":"2025","journal-title":"BJPsych Open"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/dmcn.14126","article-title":"Childhood disintegrative disorder and autism spectrum disorder: A systematic review","volume":"61","author":"Mehra","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.03.010","article-title":"Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome)","volume":"91","author":"Reierson","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/dmcn.15482","article-title":"Neurodevelopmental profile and stages of regression in Phelan-McDermid syndrome","volume":"65","author":"Dille","year":"2023","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10803-021-05023-7","article-title":"Childhood Disintegrative Disorder (CDD): Symptomatology of the Norwegian Patient Population and Parents\u2019 Experiences of Patient Regression","volume":"52","author":"Ellis","year":"2022","journal-title":"J. Autism Dev. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10803-012-1621-x","article-title":"Prevalence and onset of regression within autism spectrum disorders: A meta-analytic review","volume":"43","author":"Barger","year":"2013","journal-title":"J. Autism Dev. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/aur.2463","article-title":"Prevalence and Age of Onset of Regression in Children with Autism Spectrum Disorder: A Systematic Review and Meta-analytical Update","volume":"14","author":"Tan","year":"2021","journal-title":"Autism Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00787-002-0270-6","article-title":"Childhood disintegrative disorder","volume":"11","author":"Malhotra","year":"2002","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1177\/0883073812472391","article-title":"Childhood disintegrative disorder: Distinction from autistic disorder and predictors of outcome","volume":"28","author":"Rosman","year":"2013","journal-title":"J. Child Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1469-7610.1989.tb00784.x","article-title":"Disintegrative disorder or \u2018late onset\u2019 autism","volume":"30","author":"Volkmar","year":"1989","journal-title":"J. Child Psychol. Psychiatry"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bonne, S., Iftimovici, A., Mircher, C., Conte, M., Louveau, C., Legrand, A., Danset-Alexandre, C., Cannarsa, C., Debril, A., and Consoli, A. (2023). Down syndrome regression disorder, a case series: Clinical characterization and therapeutic approaches. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1126973"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e20192939","DOI":"10.1542\/peds.2019-2939","article-title":"Down Syndrome Disintegrative Disorder: A Clinical Regression Syndrome of Increasing Importance","volume":"145","author":"Rosso","year":"2020","journal-title":"Pediatrics"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kadam, S.D., Sullivan, B.J., Goyal, A., Blue, M.E., and Smith-Hicks, C. (2019). Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205098"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13023-022-02278-w","article-title":"A brief history of MECP2 duplication syndrome: 20-years of clinical understanding","volume":"17","author":"Ta","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/jmedgenet-2017-104956","article-title":"Further delineation of the MECP2 duplication syndrome phenotype in 59 French male patients, with a particular focus on morphological and neurological features","volume":"55","author":"Miguet","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1212\/WNL.0000000000006742","article-title":"Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome","volume":"92","author":"Marafi","year":"2019","journal-title":"Neurology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13643-023-02169-6","article-title":"Global prevalence of Rett syndrome: Systematic review and meta-analysis","volume":"12","author":"Petriti","year":"2023","journal-title":"Syst. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1073\/pnas.0507856102","article-title":"Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2","volume":"102","author":"Young","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.neuron.2024.04.007","article-title":"MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons","volume":"112","author":"Liu","year":"2024","journal-title":"Neuron"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1101\/gad.214023.113","article-title":"Emerging roles of the corepressors NCoR1 and SMRT in homeostasis","volume":"27","author":"Mottis","year":"2013","journal-title":"Genes Dev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nn.3434","article-title":"Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor","volume":"16","author":"Lyst","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuron.2015.03.059","article-title":"Gene length matters in neurons","volume":"86","author":"Zylka","year":"2015","journal-title":"Neuron"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature12504","article-title":"Topoisomerases facilitate transcription of long genes linked to autism","volume":"501","author":"King","year":"2013","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature14319","article-title":"Disruption of DNA-methylation-dependent long gene repression in Rett syndrome","volume":"522","author":"Gabel","year":"2015","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1523\/JNEUROSCI.2674-14.2014","article-title":"Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes","volume":"34","author":"Sugino","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10803-013-1902-z","article-title":"Brief report: MECP2 mutations in people without Rett syndrome","volume":"44","author":"Suter","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-8587(23)00131-6","article-title":"Rare variants in the MECP2 gene in girls with central precocious puberty: A translational cohort study","volume":"11","author":"Canton","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e000717","DOI":"10.1136\/bmjpo-2020-000717","article-title":"Consensus guidelines on managing Rett syndrome across the lifespan","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr. Open"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1866-1955-6-20","article-title":"Developmental delay in Rett syndrome: Data from the natural history study","volume":"6","author":"Neul","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg3897","article-title":"Rett syndrome: A complex disorder with simple roots","volume":"16","author":"Lyst","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Haase, F., Singh, R., Gloss, B., Tam, P., and Gold, W. (2022). Meta-Analysis Identifies BDNF and Novel Common Genes Differently Altered in Cross-Species Models of Rett Syndrome. Int. J. Mol. Sci., 23.","DOI":"10.20944\/preprints202207.0030.v1"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuropharm.2013.03.024","article-title":"BDNF deregulation in Rett syndrome","volume":"76","author":"Li","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","article-title":"Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains","volume":"66","author":"Itoh","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jmb.2019.10.004","article-title":"The Molecular Basis of MeCP2 Function in the Brain","volume":"432","author":"Tillotson","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1093\/hmg\/ddr346","article-title":"MeCP2 Rett mutations affect large scale chromatin organization","volume":"20","author":"Agarwal","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2011.03.011","article-title":"MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation","volume":"43","author":"Singleton","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6154080","DOI":"10.1155\/2016\/6154080","article-title":"Developmental Dynamics of Rett Syndrome","volume":"2016","author":"Feldman","year":"2016","journal-title":"Neural Plast."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ejpn.2002.0612","article-title":"An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001","volume":"6","author":"Hagberg","year":"2002","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ajmg.10557","article-title":"Balanced X chromosome inactivation patterns in the Rett syndrome brain","volume":"111","author":"Shahbazian","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e1917","DOI":"10.1002\/mgg3.1917","article-title":"Analysis of X-inactivation status in a Rett syndrome natural history study cohort","volume":"10","author":"Fang","year":"2022","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","article-title":"Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation","volume":"11","author":"Shahbazian","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/524110","article-title":"DNA methylation signatures within the human brain","volume":"81","author":"Pevsner","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-03182-8","article-title":"DNA methylation atlas of the mouse brain at single-cell resolution","volume":"598","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-017-0005-x","article-title":"Neural stem cells from a mouse model of Rett syndrome are prone to senescence, show reduced capacity to cope with genotoxic stress, and are impaired in the differentiation process","volume":"50","author":"Alessio","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e64833","DOI":"10.7554\/eLife.64833","article-title":"Deleting Mecp2 from the cerebellum rather than its neuronal subtypes causes a delay in motor learning in mice","volume":"10","author":"Achilly","year":"2021","journal-title":"eLife"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2024.11.006","article-title":"Acute MeCP2 loss in adult mice reveals transcriptional and chromatin changes that precede neurological dysfunction and inform pathogenesis","volume":"113","author":"Bajikar","year":"2024","journal-title":"Neuron"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/cercor\/bhv078","article-title":"Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms","volume":"26","author":"Bedogni","year":"2016","journal-title":"Cereb. Cortex"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.neurop.2024.100150","article-title":"Adolescent with neurocognitive regression as onset of atypical Rett syndrome","volume":"4","author":"Alonso","year":"2024","journal-title":"Neurol. Perspect."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/dmcn.12334","article-title":"Adolescent onset cognitive regression and neuropsychiatric symptoms associated with the A140V MECP2 mutation","volume":"56","author":"Venkateswaran","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0387-7604(85)80030-9","article-title":"Rett syndrome: Report of eight cases","volume":"7","author":"Rolando","year":"1985","journal-title":"Brain Dev."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Sahafnejad, Z., Ramazi, S., and Allahverdi, A. (2023). An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. Genes, 14.","DOI":"10.3390\/genes14040873"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","article-title":"Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics","volume":"65","author":"Brendel","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Wong, K.M., Wegener, E., Baradaran-Heravi, A., Huppke, B., G\u00e4rtner, J., and Huppke, P. (2023). Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411665"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40263-024-01106-y","article-title":"Rett Syndrome: The Emerging Landscape of Treatment Strategies","volume":"38","author":"Percy","year":"2024","journal-title":"CNS Drugs"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: A randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.tips.2023.06.008","article-title":"Trofinetide: A pioneering treatment for Rett syndrome","volume":"44","author":"Parent","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s11689-022-09446-w","article-title":"Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder","volume":"14","author":"Santoro","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molmed.2024.06.004","article-title":"Targeting epigenetic dysregulation in autism spectrum disorders","volume":"30","author":"Herrera","year":"2024","journal-title":"Trends Mol. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/11\/5361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:43Z","timestamp":1760032003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/11\/5361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":114,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26115361"],"URL":"https:\/\/doi.org\/10.3390\/ijms26115361","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}